InvestorsHub Logo
Followers 743
Posts 61825
Boards Moderated 10
Alias Born 10/05/2009

Re: None

Thursday, 11/17/2022 12:08:50 PM

Thursday, November 17, 2022 12:08:50 PM

Post# of 1245
$BIXT 10-Q just filed. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001445815/000149315222031402/form10-q.htm

Bioxytran, Inc. was organized on October 5, 2017 as a Delaware corporation, with a taxing structure for U.S. federal and state income tax as a C-Corporation with 95,000,000 authorized Common shares with a par value of $0.0001, and 5,000,000 Preferred shares with a par value of $0.0001.

On September 21, 2018, the Company underwent a reorganization in the form of a reverse merger and is currently registered as a Nevada corporation with a taxing structure for U.S. federal and state income tax as a C-Corporation with 300,000,000 authorized Common shares with a par value of $0.001, and 50,000,000 Preferred shares with a par value of $0.001.

There are currently 123,013,985 outstanding Common shares and zero Preferred shares.

Collectively, our Officers, and Directors own or exercise voting and investment control of 77,970,972 (63.4%) of our outstanding Common Stock.

Note worthy that officers/directors cancelled a pile of back pay debt about 8 weeks ago.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIXT News